Cigna Corp (CI) Position Increased by MUFG Securities EMEA plc
MUFG Securities EMEA plc increased its position in shares of Cigna Corp (NYSE:CI) by 821.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,781 shares of the health services provider’s stock after buying an additional 54,183 shares during the period. MUFG Securities EMEA plc’s holdings in Cigna were worth $11,544,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. 1 North Wealth Services LLC purchased a new position in Cigna during the fourth quarter valued at $25,000. Private Ocean LLC purchased a new position in Cigna during the fourth quarter valued at $26,000. Delta Asset Management LLC TN purchased a new position in Cigna during the fourth quarter valued at $28,000. Litman Gregory Asset Management LLC purchased a new position in Cigna during the fourth quarter valued at $30,000. Finally, Parisi Gray Wealth Management purchased a new position in Cigna during the fourth quarter valued at $32,000. 93.44% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Michael W. Triplett sold 9,148 shares of the firm’s stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $181.01, for a total transaction of $1,655,879.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John Partridge sold 1,000 shares of the firm’s stock in a transaction dated Thursday, February 7th. The stock was sold at an average price of $184.43, for a total transaction of $184,430.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,420 shares of company stock valued at $1,886,122. 1.10% of the stock is owned by company insiders.
Shares of NYSE CI opened at $166.45 on Friday. The stock has a market capitalization of $63.26 billion, a PE ratio of 11.71, a price-to-earnings-growth ratio of 0.81 and a beta of 0.73. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 0.96. Cigna Corp has a 52 week low of $162.42 and a 52 week high of $226.60.
Cigna (NYSE:CI) last released its quarterly earnings data on Friday, February 1st. The health services provider reported $2.46 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The firm had revenue of $13.75 billion for the quarter, compared to analyst estimates of $11.38 billion. During the same quarter in the previous year, the business posted $1.94 earnings per share. Cigna’s revenue for the quarter was up 29.3% on a year-over-year basis. As a group, equities research analysts predict that Cigna Corp will post 16.41 EPS for the current fiscal year.
The company also recently disclosed a special dividend, which will be paid on Wednesday, April 10th. Investors of record on Monday, March 11th will be given a dividend of $0.04 per share. The ex-dividend date is Friday, March 8th. Cigna’s payout ratio is currently 0.28%.
Cigna Company Profile
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Read More: How to invest in a bear market
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.